Rukiye Nar

723 total citations
46 papers, 482 citations indexed

About

Rukiye Nar is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Rukiye Nar has authored 46 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Epidemiology. Recurrent topics in Rukiye Nar's work include RNA modifications and cancer (6 papers), Cardiovascular Disease and Adiposity (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Rukiye Nar is often cited by papers focused on RNA modifications and cancer (6 papers), Cardiovascular Disease and Adiposity (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Rukiye Nar collaborates with scholars based in Türkiye, United States and United Kingdom. Rukiye Nar's co-authors include Hande Şenol, Gökay Nar, Esin Avcı, Alten Oskay, Murat Seyit, Atakan Yılmaz, Hülya Aybek, Mert Özen, Korhan Soylu and Sinan İnci and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Molecular and Cellular Biology.

In The Last Decade

Rukiye Nar

42 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rukiye Nar Türkiye 13 126 105 91 86 77 46 482
Supreet Kaur United States 9 58 0.5× 67 0.6× 112 1.2× 126 1.5× 38 0.5× 31 453
Muhammed Kızılgül Türkiye 16 46 0.4× 76 0.7× 86 0.9× 93 1.1× 73 0.9× 85 767
Bekir Uçan Türkiye 16 48 0.4× 77 0.7× 105 1.2× 85 1.0× 37 0.5× 82 898
Chang Chu China 16 51 0.4× 50 0.5× 40 0.4× 124 1.4× 38 0.5× 41 540
Yuhao Zhao China 10 58 0.5× 38 0.4× 33 0.4× 149 1.7× 36 0.5× 29 390
Amal Abdul‐Hafez United States 12 133 1.1× 23 0.2× 44 0.5× 121 1.4× 138 1.8× 20 595
Berta Soldevila Spain 16 22 0.2× 67 0.6× 106 1.2× 109 1.3× 73 0.9× 44 587
Jun‐Yi Luo China 11 64 0.5× 43 0.4× 52 0.6× 63 0.7× 79 1.0× 40 343
Atakan Yeşıl Türkiye 13 45 0.4× 112 1.1× 407 4.5× 45 0.5× 77 1.0× 26 750
Hang Li China 15 31 0.2× 39 0.4× 75 0.8× 149 1.7× 26 0.3× 67 736

Countries citing papers authored by Rukiye Nar

Since Specialization
Citations

This map shows the geographic impact of Rukiye Nar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rukiye Nar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rukiye Nar more than expected).

Fields of papers citing papers by Rukiye Nar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rukiye Nar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rukiye Nar. The network helps show where Rukiye Nar may publish in the future.

Co-authorship network of co-authors of Rukiye Nar

This figure shows the co-authorship network connecting the top 25 collaborators of Rukiye Nar. A scholar is included among the top collaborators of Rukiye Nar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rukiye Nar. Rukiye Nar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Fang, Shikan Zheng, Chunjie Yu, et al.. (2025). KRAS mutants confer platinum resistance by regulating ALKBH5 posttranslational modifications in lung cancer. Journal of Clinical Investigation. 135(6). 5 indexed citations
2.
Nar, Rukiye, Zhixing Wu, Yafang Li, et al.. (2024). Targeting METTL3 protein by proteolysis-targeting chimeras: A novel therapeutic approach for acute myeloid leukemia. Genes & Diseases. 12(4). 101452–101452. 6 indexed citations
3.
Hacıoğlu, Sibel, et al.. (2021). Is CONUT score a prognostic index in patients with diffuse large cell lymphoma?. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(4). 2112–2119. 12 indexed citations
4.
Sarı, Tuğba, et al.. (2021). Serum microRNA signature is capable of predictive and prognostic factor for SARS-COV-2 virulence. Turkish Journal of Biochemistry. 46(3). 245–253. 21 indexed citations
5.
Nar, Gökay, et al.. (2021). Is serum fibroblast growth factor 21 associated with the severity or presence of coronary artery disease?. Journal of Medical Biochemistry. 41(2). 162–167. 5 indexed citations
6.
Nar, Rukiye, et al.. (2021). Regulation of RNA Polymerase II Transcription Initiation and Elongation by Transcription Factor TFII-I. Frontiers in Molecular Biosciences. 8. 681550–681550. 10 indexed citations
7.
Nar, Rukiye, et al.. (2021). Evaluation of the relationship between viral load and biochemical parameters in Covid-19 patients. SHILAP Revista de lepidopterología. 10(2). 469–469. 1 indexed citations
8.
Nar, Gökay, et al.. (2021). Retinol binding protein 4 levels relate to the presence and severity of coronary artery disease. Journal of Medical Biochemistry. 40(4). 384–389. 5 indexed citations
9.
Wu, Qiong, Rukiye Nar, Marjorie Brand, et al.. (2020). TFII-I/Gtf2i and Erythro-Megakaryopoiesis. Frontiers in Physiology. 11. 590180–590180. 5 indexed citations
10.
Çelık, Mustafa, et al.. (2020). Serum omentin-1 levels in hypertensive patients. Journal of Human Hypertension. 35(3). 290–295. 17 indexed citations
12.
Nar, Rukiye, Álex Pérez, Masatoshi Ikeda, et al.. (2018). Identification of a Novel Enhancer/Chromatin Opening Element Associated with High-Level γ -Globin Gene Expression. Molecular and Cellular Biology. 38(19). 4 indexed citations
13.
Nar, Rukiye, et al.. (2017). BİYOKİMYA LABORATUVARINDA PRE-PREANALİTİK HATA KAVRAMI. DergiPark (Istanbul University). 1(1). 23–24. 1 indexed citations
14.
Nar, Rukiye, Alex Xiu‐Cheng Fan, Mir Ahamed Hossain, et al.. (2017). Functional interrelationship between TFII‐I and E2F transcription factors at specific cell cycle gene loci. Journal of Cellular Biochemistry. 119(1). 712–722. 8 indexed citations
15.
Nar, Gökay, Özkan Görgülü, Sinan İnci, et al.. (2016). Galectin-3 as a novel biomarker for the diagnosis of essential hypertension with left ventricular hypertrophy. Journal of Experimental & Clinical Medicine. 33(3). 123–128. 4 indexed citations
16.
Aksan, Gökhan, Sinan İnci, Gökay Nar, et al.. (2015). Serum Neutrophıl Gelatınase-Assocıated Lıpocalın Levels in Patients with Non-Dipper Hypertension. Clinical and investigative medicine. 38(1). 53–53. 6 indexed citations
17.
Soylu, Korhan, Gökay Nar, Gökhan Aksan, et al.. (2014). Serum Neutrophil Gelatinase-Associated Lipocalin Levels and Aortic Stiffness in Noncritical Coronary Artery Disease. Cardiorenal Medicine. 4(3-4). 147–154. 13 indexed citations
18.
Nar, Gökay, et al.. (2014). The relationship between epicardial fat thickness and gestational diabetes mellitus. Diabetology & Metabolic Syndrome. 6(1). 120–120. 17 indexed citations
19.
Nar, Gökay, Korhan Soylu, Murat Akçay, et al.. (2013). Evaluation of the Relationship Between Arterial Blood Pressure, Aortic Stiffness and Serum Endothelin-1 Levels in Patients with Essential Hypertension. Clinical and Experimental Hypertension. 35(8). 589–594. 11 indexed citations
20.
Nar, Rukiye, et al.. (2012). Ouabain Targets the Unfolded Protein Response for Selective Killing of HepG2 Cells During Glucose Deprivation. Cancer Biotherapy and Radiopharmaceuticals. 27(8). 457–463. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026